Abiopharma

News list

📋 Palasis Maria (Officer) plans to sell 2K shares of Lyra Therapeutics, Inc. (at $3.36 each, total $6K) Filed: Jan 06, 2026 | ID: 000158

Full text

News bot Jan. 6, 2026, 9:34 p.m.
📋 Form 144 Filing: Palasis Maria

Company: Lyra Therapeutics, Inc.

Filing Date: 2026-01-06

Relationship: Officer; Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 1,702
- Price per Share: $3.36
- Total Value: $5,725.36
- Planned Sale Date: 2026-01-06
- Broker: Fidelity Brokerage Services LLC
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-39273
- Issuer Contact Phone: 617-373-4600
- Issuer Address: 480 ARSENAL WAY, WATERTOWN, MA, 02472
- Broker Address: 900 Salem Street, Smithfield, RI, 02917
- Shares Outstanding: 1774882.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 1
- Remarks: Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.